Sulodeksid

Sulodeksid
Klinički podaci
Drugs.com	Monografija
Farmakokinetički podaci
Poluvreme eliminacije	11,7 h

Identifikatori
CAS broj	57821-29-1^Y
ATC kod	B01AB11 (WHO)
DrugBank	DB06271^Y

Sulodeksid je visoko prečišćena smeša glikozaminoglikanskih jedinjenja heparina niske molekularske težine (80%) i dermatan sulfata (20%).^[1]^[2]^[3]^[4]

Reference

^ Cosmi, B.; Cini, M.; Legnani, C.; Pancani, C.; Calanni, F.; Coccheri, S. (2003). „Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans”. Thrombosis Research. 109 (5–6): 333—339. PMID 12818259. doi:10.1016/s0049-3848(03)00246-9.
^ Harenberg, J. (јануар 1998). „Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide”. Medicinal Research Reviews. 18 (1): 1—20. PMID 9436179. S2CID 26366651. doi:10.1002/(sici)1098-1128(199801)18:1<1::aid-med1>3.0.co;2-4. CS1 одржавање: Формат датума (веза)
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. уреди
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958. уреди

Literatura

Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.